Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: SRS who wrote (981)	5/29/1998 1:45:00 AM
From: John Dwyer	Respond to of 3576

Thanks for the link... it looks like GERN will be making several presentations at this conference, including some related to cancer. I think there could be a great deal of interest here since other cancer stocks have been in the limelight recently. GERN has a much better "story" than some of these other stocks, IMO. Anybody care to speculate on what might be presented? I've found the excuse I was looking for to buy GERN... ;^) John

To: SRS who wrote (981)	5/29/1998 2:54:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3576

SRS..... A friend also pointed me to the program. It seems like GERN roles out *the* fresh science for these small meetings, and this one seems to have a particularly academic feel. There's a review of telomerase, and kissing Hayflick goodbye, in the latest issue of Nature Biotechnology. It's authored by Harry Rubin, a non-believer. It will be fun to see how that debate fires up, but it's the cancer story that I'm most interested in. Harley is keynote at lunch on Tuesday and Funk (no abstract, damn it) is talking on Wednesday. Thanks for bringing this up. Rick